Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 863

1.

ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.

Wiestner A, Rosenwald A, Barry TS, Wright G, Davis RE, Henrickson SE, Zhao H, Ibbotson RE, Orchard JA, Davis Z, Stetler-Stevenson M, Raffeld M, Arthur DC, Marti GE, Wilson WH, Hamblin TJ, Oscier DG, Staudt LM.

Blood. 2003 Jun 15;101(12):4944-51.

2.

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, Marcé S, López-Guillermo A, Campo E, Montserrat E.

N Engl J Med. 2003 May 1;348(18):1764-75.

4.

Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors.

Oscier DG, Gardiner AC, Mould SJ, Glide S, Davis ZA, Ibbotson RE, Corcoran MM, Chapman RM, Thomas PW, Copplestone JA, Orchard JA, Hamblin TJ.

Blood. 2002 Aug 15;100(4):1177-84.

5.

ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemia.

Catherwood MA, Matthews C, Niblock R, Dobbin E, Morris TC, Alexander HD.

Eur J Haematol. 2006 Apr;76(4):294-8.

PMID:
16519700
6.

Expression of ZAP-70 protein correlates with disease stage in chronic lymphocytic leukemia and is associated with, but not generally restricted to, non-mutated Ig VH status.

Kim SZ, Chow KU, Kukoc-Zivojnov N, Boehrer S, Brieger A, Steimle-Grauer SA, Harder L, Hoelzer D, Mitrou PS, Weidmann E.

Leuk Lymphoma. 2004 Oct;45(10):2037-45.

PMID:
15370248
7.

Different gene expression in immunoglobulin-mutated and immunoglobulin-unmutated forms of chronic lymphocytic leukemia.

Ferrer A, Ollila J, Tobin G, Nagy B, Thunberg U, Aalto Y, Vihinen M, Vilpo J, Rosenquist R, Knuutila S.

Cancer Genet Cytogenet. 2004 Aug;153(1):69-72.

PMID:
15325098
8.

Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.

Schroers R, Griesinger F, Trümper L, Haase D, Kulle B, Klein-Hitpass L, Sellmann L, Dührsen U, Dürig J.

Leukemia. 2005 May;19(5):750-8.

PMID:
15759031
9.

V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia.

Kröber A, Seiler T, Benner A, Bullinger L, Brückle E, Lichter P, Döhner H, Stilgenbauer S.

Blood. 2002 Aug 15;100(4):1410-6.

10.

Comparative analysis of ZAP-70 expression and Ig VH mutational status in B-cell chronic lymphocytic leukemia.

Muñoz L, Lasa A, Carricondo MT, Hernández C, Ubeda J, Nomdedéu JF.

Cytometry B Clin Cytom. 2007 Mar;72(2):96-102.

11.

The prognostic evaluation of CLLU1 expression levels in 50 Chinese patients with chronic lymphocytic leukemia.

Chen L, Li J, Zheng W, Zhang Y, Wu Y, Li L, Qian S, Xu W.

Leuk Lymphoma. 2007 Sep;48(9):1785-92.

PMID:
17786715
12.

Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.

Gachard N, Salviat A, Boutet C, Arnoulet C, Durrieu F, Lenormand B, Leprêtre S, Olschwang S, Jardin F, Lafage-Pochitaloff M, Penther D, Sainty D, Reminieras L, Feuillard J, Béné MC; GEIL..

Haematologica. 2008 Feb;93(2):215-23. doi: 10.3324/haematol.11622.

13.

Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia.

Chen L, Zhang Y, Zheng W, Wu Y, Qiao C, Fan L, Xu W, Li J.

Leuk Res. 2008 Oct;32(10):1491-8. doi: 10.1016/j.leukres.2008.02.005.

PMID:
18359082
14.

ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia.

Rassenti LZ, Huynh L, Toy TL, Chen L, Keating MJ, Gribben JG, Neuberg DS, Flinn IW, Rai KR, Byrd JC, Kay NE, Greaves A, Weiss A, Kipps TJ.

N Engl J Med. 2004 Aug 26;351(9):893-901.

15.

Zap-70 and CD38 as predictors of IgVH mutation in CLL.

Cruse JM, Lewis RE, Webb RN, Sanders CM, Suggs JL.

Exp Mol Pathol. 2007 Dec;83(3):459-61.

PMID:
17931624
16.

Expression level of lipoprotein lipase in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors.

Xu W, Li JY, Shen QD, Wu YJ, Yu H, Fan L.

Int J Lab Hematol. 2009 Oct;31(5):552-9. doi: 10.1111/j.1751-553X.2008.01078.x.

PMID:
18616755
17.

The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia.

Oppezzo P, Vasconcelos Y, Settegrana C, Jeannel D, Vuillier F, Legarff-Tavernier M, Kimura EY, Bechet S, Dumas G, Brissard M, Merle-Béral H, Yamamoto M, Dighiero G, Davi F; French Cooperative Group on CLL..

Blood. 2005 Jul 15;106(2):650-7.

18.

Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia.

Kröber A, Bloehdorn J, Hafner S, Bühler A, Seiler T, Kienle D, Winkler D, Bangerter M, Schlenk RF, Benner A, Lichter P, Döhner H, Stilgenbauer S.

J Clin Oncol. 2006 Feb 20;24(6):969-75.

PMID:
16418492
19.

IgVH genes mutation and usage, ZAP-70 and CD38 expression provide new insights on B-cell prolymphocytic leukemia (B-PLL).

Del Giudice I, Davis Z, Matutes E, Osuji N, Parry-Jones N, Morilla A, Brito-Babapulle V, Oscier D, Catovsky D.

Leukemia. 2006 Jul;20(7):1231-7.

PMID:
16642047
20.

[Lipoprotein lipase and serum thymidine kinase level in chronic lymphocytic leukemia and their correlations with other prognostic factors].

Xu W, Shen QD, Yu H, Qiao C, Wu YJ, Liu Q, Zhu DX, Miao KR, Li JY.

Zhonghua Xue Ye Xue Za Zhi. 2009 Jan;30(1):8-12. Chinese.

PMID:
19563027

Supplemental Content

Support Center